Taking page from early AIDS activists, ALS patients push for access to ...

San Francisco Business Times (blog) - 3 weeks ago
Ultimately, they hope to convince...

Treasure Valley bandwidth: a mixed bag

The Idaho Statesman - 1 week ago
About two years ago, Saint...

SORL1 rare variants: a major risk factor for familial early-onset Alzheimer's ...

Nature.com - 5 days ago
Only patients with no PSEN1, PSEN2...

ALS research already benefiting from Ice Bucket Challenge's return

WCVB Boston - 4 weeks ago
For patients like Bobby Forster,...

US FDA Accepts BOTOX® (onabotulinumtoxinA) Resubmission for the Treatment of ...

MarketWatch - 1 week ago
The expanded label now includes...

Editorial: 'Right to Try' experimental drugs offers both hope and risk

Chicago Daily Herald - 3 weeks ago
Right To Try legislation is...

IO doesn't want to call Hitman an Early Access game in case it gives people ...

Videogamer.com - 3 weeks ago
Some fans have previously compared...

Panasonic entwickelt Bleche mit integrierter elektromagnetischer ...

SYS-CON Media (press release) - 1 week ago
Die Panasonic Corporation hat...

Pivotal kündigt Veränderungen in der Unternehmensleitung und Rekordergebnisse an

SYS-CON Media (press release) - 2 weeks ago
Herr Maritz spielte eine große...

News via Google. See more news matching 'als expanded access'

Treatment Options Equal Real Hope

ALS Emergency Treatment Fund was built to sponsor Expanded Access treatment programs (EAPs) that bring clinics and patients the option to try new medicines that are in clinical trials.  Learn more…

Your Name (required)

Your Email (required)

Latest news on ALS Research

UMass researchers probe genetic mutation in ALS study

Worcester Telegram - 22 hours ago
Mr. Gao said he couldn't predict when an effective treatment for ALS or FTD would be found....

Crosby: ALS research news hits close to home

Chicago Tribune - 3 days ago
The U.S. Food and Drug Administration designated NurOwn as a "fast-track product" to...

How Common Dysfunction Causes ALS

HealthNewsDigest.com - 3 days ago
The research was funded in part by grants (N079725, NS079725, AG019724) from the National...

Researchers reveal how a common mutation causes neurodegenerative disease

News from the University of Massachusetts - 3 days ago
... within five years of diagnosis.” The research was funded in part by grants from the National...

Two families, one disease, no cure ... yet

NorthernLife.ca - 3 days ago
... Josée Belanger-Leroux, Joanne Perreault, Gates Perreault with one of the buckets from the ALS...

News via Google. See more news matching 'als treatment research'

Latest news on EAP’s

Progressing Towards Clinical Trials: Kadimastem Proves Efficacy of Its Unique ...

Business Wire (press release) - 2 weeks ago
NESS ZIONA, Israel--(BUSINESS WIRE)--Israeli biotechnology company Kadimastem (TASE: KDST) reports...

BrainStorm Cell Therapeutics Announces Completion of Enrollment in Phase 2 ...

MarketWatch - 3 weeks ago
Merit Cudkowicz, MD, Professor of Neurology at Harvard Medical School, Director of the ALS Clinical...

What the Planned Parenthood Videos Leave Out: Fetal Tissue Can Treat Terrible ...

Slate Magazine - 4 weeks ago
The first Food and Drug Administration–approved clinical trials to treat ALS with fetal stem...

Crosby: ALS research news hits close to home

Chicago Tribune - 3 days ago
When I talked to the 58-year-old man on Tuesday, he and wife Meredith were on their way to Mayo...

Multi-center ALS Study Using the NeuRx® Diaphragm Pacing System™ (DPS) Shows ...

PR Newswire (press release) - 5 days ago
CLEVELAND, Aug. 25, 2015 /PRNewswire/ -- Synapse Biomedical Inc. (www.synapsebiomedical.com)...

News via Google. See more news matching 'als clinical trial'

BIO2014 Conference

June 23-26, 2014
San Diego, CA
ALS-ETF's Rabourn and Bowser conducted workshop on Biomarker Discovery

NEALS 2014 Meeting

Oct. 22 - 24, 2014
Clearwater Beach, FL
ALS-ETF's Rabourn and Bedlack to present opportunity of Expanded Access in ALS.

ALS/MND Symposium 2014

Dec. 5 - 7, 2014
Brussels, Belgium
Largest gathering of ALS researchers in the world. Annual.

Biotech Showcase 2015

Jan. 12-14, 2015
San Francisco, CA
Massive showcase event for emerging therapeutics in unsolved diseases. Part of JP Morgan Week in SF.
  • FasterCures
  • ALS Untangled
  • ALS WorldWide
  • BIO
  • BayBio
  • Trophos
  • NORD
  • ALS Registry
  • MyTomorrows
  • The 24 Hour HeroThe 24 Hour Hero